KRAIG BIOCRAFT LABS INC - KBLB STOCK NEWS

Kraig Biocraft Laboratories (OTCQB: KBLB) has announced a significant advancement in its production capabilities with the installation of new lab equipment at its Vietnam-based subsidiary, Prodigy Textiles. This advancement allows for onsite testing and screening of spider silk transgenic technologies, enabling a full transfer of genetic screening and selection operations. The new onsite lab aims to mitigate past delays caused by COVID-related shipping issues, allowing Prodigy to scale operations to maximum capacity more efficiently. This move is seen as a pivotal step towards building a completely autonomous production operation.

Kraig Biocraft Laboratories (KBLB) announced in a recent shareholder letter that it is entering 2022 in a strong financial position. CEO Kim Thompson highlighted advancements in production and commercialization of spider silk-based fibers. Key developments include the introduction of automation in their Vietnamese subsidiary, Prodigy Textiles, and the establishment of a new onsite laboratory. These enhancements are set to improve production capacity and quality control, paving the way for fulfilling a backlog of material requests. A recent $5 million investment also positions KBLB for potential institutional funding in the upcoming year.

Kraig Biocraft Laboratories (OTCQB: KBLB) announces that its spider silk technology was featured on the BBC Earth series “Inspired By Nature.” The episode highlights the company’s advancements in genetically engineered spider silk fibers, renowned for their strength and applicability in various industries. COO Jon Rice emphasized that the company’s approach is to replicate natural processes rather than reinventing them. Viewers can see clips on BBC Earth’s Facebook page and find more details on Kraig Labs’ website.

Kraig Biocraft Laboratories is expanding its production capabilities in Vietnam by planting several acres of mulberry trees at its spider silk production campus. This initiative aims to overcome supply challenges during winter months and minimize high costs associated with mulberry procurement. The company will still collaborate with local cooperatives for summer supply but anticipates that onsite production will streamline its operations and ensure quality control. The January installation of new lab equipment will enhance its production capacity, positioning Kraig Labs as a leader in sustainable spider silk fiber production.

Kraig Biocraft Laboratories (OTCQB: KBLB) has initiated the production of its fourth generation of specialized spider silk silkworms at a new production campus in Vietnam. This follows the successful completion of the third generation in mid-November. The company has expanded production capacity and improved yields since relocating its operations in August. The facility includes dedicated lab space and over 7 acres dedicated to mulberry cultivation. Kraig Labs plans to spin raw silk into custom yarns for its SpydaSilk brand, while also addressing COVID-19 related workforce challenges.

Kraig Biocraft Laboratories (OTCQB: KBLB) announces that easing COVID-19 restrictions in Vietnam has revitalized its operations. The company, focused on spider silk production, faced delays due to pandemic restrictions, but is now poised to enhance silkworm production. Upcoming delivery of advanced quality control lab equipment will boost operational capabilities. With textile mills reopening, Kraig Labs is excited to resume the production of SpydaSilk apparel in partnership with Kings Golden Harvest, paving the way for new market opportunities.

Kraig Biocraft Laboratories (OTCQB: KBLB) has initiated challenge testing for its immunity-enhanced silkworms, designed to combat devastating viral and fungal infections impacting global silk production. With up to 50% of losses attributed to a specific virus affecting 75% of producers, Kraig Labs aims to license these disease-resistant silkworms to mitigate significant economic losses in the $14B silk industry. Successful testing could lead to commercial availability, further advancing their commitment to cost-effective and environmentally sustainable silk solutions.

Kraig Labs has filed a provisional patent for a groundbreaking gene-editing system that enhances the production of recombinant spider silk. This new knock-out/knock-in multiplex system significantly reduces process complexity by over 60%, potentially leading to higher yields. The research team is currently monitoring first-generation transgenics, with results expected in 30 days. Kraig Labs aims to apply this technology beyond silk, with implications for boutique protein production. COO Jon Rice highlighted the innovative team's achievements in unlocking cost-effective, commercial-scale production.

Kraig Biocraft Laboratories (OTCQB: KBLB) announced it will conduct challenge testing on two lines of immunity-enhanced silkworms to address significant losses in the silk industry caused by a widespread virus. Reportedly, 50% of silk production losses stem from this virus, affecting the economic viability of many producers. The company aims to license these transgenic silkworms globally, anticipating availability for commercial licensing post-successful testing. Kraig Labs continues to focus on the commercialization of eco-friendly recombinant spider silk.